Hester Biosciences Limited (HESTERBIO)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
2236
-7.55(-0.34%)

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India. It operates through Poultry healthcare, Animal Healthcare, and Others segments. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals against Goat Pox, Peste des Petits Ruminants, and Brucellosis diseases, as well as infections, reproductive disorders, theileriosis, and parasitic diseases. In addition, the company provides feed supplements, such as growth tonic, toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment; herbal and nutrition products; and sanitizers. The company also exports its products. Hester Biosciences Limited has a collaboration agreement with Indian Institute of Technology Guwahati to develop vaccine against COVID-19. The company was incorporated in 1987 and is headquartered in Ahmedabad, India.

Pricing Updates

TODAY'S HIGH

2292.2

TODAY'S LOW

2223

52 WEEK HIGH

3105

52 WEEK LOW

2131.25

Major Holders

% of Shares Held by
All Insider

63.35%

% of Shares Held by
Institutions

0.37%

% of Float Held by
Institutions

1.00%

Number of Institutions
Holding Shares

4

Company Overview

MARKET CAP

1911.85 Cr.

ETERPRISE VALUE

0

NO. OF SHARES

85.06 Lakhs

BOOK VALUE

299.99

DIV. YIELD

10%

DEBT

0

GROSS PROFIT

0

CASH

0

REVENUE

''

REVENUE/SHARE

None

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments01.06 Cr.-2.33 Cr.65.89 Lakhs
Change To Liabilities08.06 Cr.9.86 Cr.61.05 Lakhs
Total cashflows from Investing Activities0-38.37 Cr.-74.47 Cr.-21.72 Cr.
Net Borrowings0-22.89 Cr.28.16 Cr.18.96 Cr.
Total Cash from Financing Activities0-18.21 Cr.18.74 Cr.2.65 Cr.
Other Liabilities0-18.83 Cr.15.20 Cr.-8.38 Cr.
Total Assets0000
Net Income034.43 Cr.29.17 Cr.41.56 Cr.
Change in Cash0-2.26 Cr.-17.11 Cr.28.31 Cr.
Effect of Exchange Rate0-3.72 Cr.1.84 Cr.1.84 Cr.
Total Cash from Operating Activities058.05 Cr.36.77 Cr.46.70 Cr.
Depreciation013.26 Cr.13.17 Cr.11.69 Cr.
Other Cashflows from Investing Activities01.26 Cr.37.40 Lakhs15.23 Lakhs
Dividends Paid0-5.61 Cr.-5.95 Cr.-10.25 Cr.
Change to Inventory01.74 Cr.-13.18 Cr.-10.36 Cr.
Change to Account Receivables08.24 Cr.-25.63 Cr.5.88 Cr.
Other Cashflows from Financing Activities010.29 Cr.-3.47 Cr.-6.05 Cr.
Change to Net Income011.08 Cr.8.11 Cr.4.89 Cr.
Capital Expenditures0-40.74 Cr.-73.49 Cr.-22.65 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax050.10 Cr.41.32 Cr.56.85 Cr.
Minority Interest07.65 Cr.5.42 Cr.3.69 Cr.
Net Income059.12 Cr.46.85 Cr.62.57 Cr.
Selling General Administrative045.88 Cr.53.70 Cr.28.92 Cr.
Gross Profit0164.98 Cr.157.51 Cr.155.69 Cr.
Ebit059.12 Cr.46.85 Cr.62.57 Cr.
Operating Income059.12 Cr.46.85 Cr.62.57 Cr.
Other Operating Expenses045.98 Cr.43.82 Cr.52.42 Cr.
Interest Expense0-6.06 Cr.-6.38 Cr.-5.30 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense015.40 Cr.10.32 Cr.16.16 Cr.
Total Revenue0217.69 Cr.187.76 Cr.184.16 Cr.
Total Operating Expenses0158.57 Cr.140.90 Cr.121.58 Cr.
Cost of Revenue052.70 Cr.30.24 Cr.28.47 Cr.
Total Other Income Expense Net0-9.01 Cr.-5.53 Cr.-5.72 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.034.69 Cr.31 Cr.40.69 Cr.
Net Income Applicable to Common Shares034.43 Cr.29.17 Cr.41.56 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets042.10 Lakhs39.30 Lakhs47.98 Lakhs
Capital Surplus017.50 Cr.17.50 Cr.17.50 Cr.
Total Liabilities0175.09 Cr.180.11 Cr.118.29 Cr.
Stock Holder Equity0228.30 Cr.201.07 Cr.177.45 Cr.
Minority Interest07.65 Cr.5.42 Cr.3.69 Cr.
Other Liabilities08.54 Cr.18.34 Cr.7.47 Cr.
Total Assets0411.04 Cr.386.60 Cr.299.45 Cr.
Common Stock08.50 Cr.8.50 Cr.8.50 Cr.
Retained Earnings0193.47 Cr.164.44 Cr.143.19 Cr.
Other Liabilities025.69 Cr.14.97 Cr.11.28 Cr.
Good Will0000
Treasury Stock08.82 Cr.10.61 Cr.8.24 Cr.
Other Assets04.98 Cr.6.73 Cr.4.34 Cr.
Cash021.26 Cr.23.53 Cr.40.64 Cr.
Current Liabilities061.36 Cr.83.46 Cr.48.66 Cr.
Long Term Asset Charges0000
Short Long Term Debt018.28 Cr.11.50 Cr.8.92 Cr.
Other Stockholder Equity08.82 Cr.10.61 Cr.8.24 Cr.
Property Plant Equipment0241.33 Cr.216.29 Cr.151.39 Cr.
Total Cur. Assets0161.50 Cr.159.31 Cr.141.65 Cr.
Long Term Investments02.80 Cr.3.86 Cr.1.58 Cr.
Net Tangible Assets0227.88 Cr.200.67 Cr.176.97 Cr.
Short Term Investments0000
Net Receivables067.45 Cr.58.74 Cr.33.23 Cr.
Long Term Debt082.50 Cr.75.67 Cr.58.10 Cr.
Inventory062.22 Cr.63.96 Cr.50.78 Cr.
Accounts Payable028.08 Cr.20.02 Cr.8.75 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account